Category Archives: Announcement

Family Pharm Podcast – RELAUNCHED!

After a 6-month hiatus, Tina – now a newly-hatched PHARMACIST! – and Billy teamed up to relaunch this pet project with a plan to make it more interactive and less sleep-inducing. Did it work with this unscripted episode?

Milestone: We Are Officially Not “New” Anymore

Thanks to your support, since being listed on the iTunes Store, we have been featured quite highly on the “New and Noteworthy” section on the Medicine category in Canada. Today, with some mixed feelings, we found ourselves graduating from that list and officially took off our “New” hat.

iTunes Store reportedly feature new podcasts on their New and Noteworthy list for a maximum of about 8 weeks, but that may have changed since we were on the list for a little over 3 months. I am not sure how many listeners found out about our podcast purely by stumbling across it on this list on iTunes (those of you who did, say aye?), so I can’t say whether being off the list would slow down our reach drastically. But I sure would miss seeing our humble little logo!

As mentioned in the intro chit chat of our last podcast, we had the chance to sat through the entire Family Pharm Podcast catalogue. The 5-hour marathon has led to some soul-searching and suffice it to say, we are brainstorming ways to improve the podcast in the future.

As we move forward from being a featured new podcast, we hope this will also mark a transition of maturation in our little project.

Until then, thank you for listening, and we’ll talk to you next time!

Diabetes 3: Insulin and Official Launch

Classes of insulin and different treatment regimens are discussed in the third episode of a 3-part series on diabetes. This episode also marks the conclusion of our coverage of the “Big Three” of modern medicine (hypertension, dyslipidemia, and diabetes), and with it, we make an official announcement of the launch of the Family Pharm Podcast to the world (aka Facebook)!

 

Class Drug Onset Peak Duration
Very Rapid-acting Insulin Analogues insulin aspart
(NovoRapid)
10–15 min 60–90 min 4–5 h
insulin glulisine
(Apidra)
insulin lispro
(Humalog)
Rapid-acting Insulin insulin regular
(Humulin R, Novolin ge Toronto)
30–60 min 2–4 h 5–8 h
Intermediate-acting Insulin insulin NPH
(Humulin N, Novolin ge NPH)
1–2 h 5–8 h 14–18 h
Long-acting Insulin Analogues insulin detemir
(Levemir)
1.5 h Flat, no discernible peak 24 h
insulin glargine
(Lantus)
Mixed (regular/NPH) Human Insulin insulin regular/insulin NPH
Humulin 30/70,
Novolin ge 30/70, 40/60, 50/50
Combination of individual components
Mixed Insulin Analogues insulin lispro/lispro protamine
Humalog Mix25, Humalog Mix50
10–15 min Not available Not available
Mixed Insulin Analogues insulin aspart/aspart protamine
NovoMix 30
10–15 min 60–90 min 15–18 h

Classes of insulin preparations. Adapted from Therapeutic Choices 6th edition.

CDA guideline on insulin for Type 1 diabetes, including description of basal-bolus regimen by carb counting:

Examples of insulin regimens from CDA:

Self monitoring: